All Type of News
While Mercilon is leading the contraceptive market, Bayer is having complex concerns
‘Mercilon’ is dominating in the pre-coital contraception pill market. Last year, it first exceeded KRW 10 billion sales to leave other pharmaceutical products behind.
Bayer Healthcare, planning to absorb the owning c...
Foreign direct investments of the domestic pharmaceutical industry in 2014 recorded the most ever
It is known that funds invested directly in foreign markets last year recorded the most ever in the history.
According to the ‘2014 Trend Analysis of Direct Investment to Foreign Markets by the Domestic Pharmaceutica...
The Korea Pharmaceutical Distribution Association will aim Pfizer Korea and Novartis
The Korea Pharmaceutical Distribution Association (KPDA) is going to face the full-scale war against Pfizer Korea and Novartis to secure reasonable pharmaceutical distribution cost.
Based on the winnings against seve...
Patent challenges are ongoing in 34 original products
Did it target the enforcement of the Patent Linkage System and the Priority Sale Item Approval System? The pharmaceutical industry is actively having patent challenges. The number of originals challenged by generics h...
Pfizer stated “After administering Champix, alcohol and seizure are not related”When it comes to the Ministry of Food and Drug Safety’s antismoking supplement, Champix (varenicline), distribution of safety letters has been controversy.
The safety letters w...
|
Will the competition between Levemir·Victoza and Lantus·Lyxumia get severe?
As the beneficiary standard for diabetes has been changed since the 1st, basal insulins have been reevaluated. It seems that prescriptions of insulins will increase due to the changed beneficiary standard and recognit...
GSK withdrew the plan to reduce the number of client wholesale companiesIt is known that GSK has withdrawn the reduction plan on the number of distribution companies.
According to the pharmaceutical distribution industry, GSK has shown a movement t...
|
‘Nesina Act’ that improved the fundamental cause of diabetes is expected to shake the market
The first complex of alogliptin and a TZD type composite, ‘Nesina Act’, has attracted attention.
Takeda Pharmaceuticals Korea unveiled at the press conference on 11th that the new drug ‘Nesina Act’, having the DDP-4 ...
What are the future movements of Shire Korea?
A Korean branch of the British pharmaceutical company, Shire, which was in the middle of the global M&A issue last year, also known as Shire Korea, cleared the industry.
In order to establish the domestic branch, Shi...
Approximately 18,000 institutions have participated in the antismoking counseling program today, the 10th
As the number of medical institutions that would like to participate in the demonstration project of antismoking counseling is 18,399 on the 10th, it is confirmed that the medical industry is incredibly interested in ...
